DSIP 5 mg

DSIP (Delta Sleep-Inducing Peptide) is a small endogenous neuropeptide belonging to the class of regulatory brain peptides. It is a nonapeptide composed of nine amino acid residues with the primary sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). The peptide was first isolated in 1974 by the Schoenenberger-Monnier group in Switzerland from the cerebral venous blood of rabbits during an induced sleep state, and the material supplied here is produced by chemical synthesis for laboratory use.

In preclinical and animal-model research, DSIP has been investigated for its proposed role in the regulation of sleep architecture, where studies have reported associations with delta-wave (slow-wave) sleep activity. It has also been examined in laboratory settings as a candidate modulator of the hypothalamic-pituitary-adrenal (HPA) axis and stress-response signaling, including reported effects on corticotropin and corticosterone levels in rodent models. Additional in-vitro and animal investigations have explored its interactions with neuroendocrine pathways and its possible cytoprotective and oscillatory signaling properties. All such findings derive from controlled experimental research and have not been established in humans.

Specifications: CAS 62568-57-4 · Molecular formula C35H48N10O15 · Molecular weight 848.8 g/mol · Sequence/length 9 amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) · Form lyophilized powder · Available sizes Default

Storage & handling: store the lyophilized powder at -20C and protect it from light. For research preparation, reconstitute with bacteriostatic (BAC) water; keep the reconstituted solution refrigerated and use it within a few weeks.

For research use only. Not for human consumption. This product is not a drug, food, or dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.